Show simple item record

dc.contributor.authorCatalini, Valeria
dc.contributor.authorArillotta, Davide
dc.contributor.authorCorkery, John Martin
dc.contributor.authorGuirguis, Amira
dc.contributor.authorVento, Alessandro
dc.contributor.authorSchifano, Fabrizio
dc.date.accessioned2021-02-09T10:00:20Z
dc.date.available2021-02-09T10:00:20Z
dc.date.issued2021-02-09
dc.identifier.citationCatalini , V , Arillotta , D , Corkery , J M , Guirguis , A , Vento , A & Schifano , F 2021 , ' Identifying new/emerging psychoactive substances at the time of COVID-19; a web-based approach ' , Frontiers in Psychiatry , vol. 11 , 632405 . https://doi.org/10.3389/fpsyt.2020.632405
dc.identifier.issn1664-0640
dc.identifier.otherPURE: 24174921
dc.identifier.otherPURE UUID: 24a9b08d-65d4-4aec-ac35-dca06036a804
dc.identifier.otherScopus: 85101562696
dc.identifier.otherPubMed: 33633599
dc.identifier.urihttp://hdl.handle.net/2299/23880
dc.description© 2021 Catalani, Arillotta, Corkery, Guirguis, Vento and Schifano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).https://creativecommons.org/licenses/by/4.0/
dc.description.abstractCOVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aims of the current research were to use a web crawler, NPSfinder®, to identify and categorize emerging NPS discussed on a range of drug enthusiasts/psychonauts' websites/fora at the time of the pandemic; social media for these identified NPS were screened as well. The NPSfinder® was used here to automatically scan 24/7 a list of psychonaut websites and NPS online resources. The NPSs identified in the time frame between January and August 2020 were searched in both the European Monitoring Center for Drugs and Drug Addictions (EMCDDA)/United Nations Office on Drugs and Crime (UNODC) databases and on social media (Facebook, Twitter, Instagram, Pinterest, and YouTube) as well, with a content qualitative analysis having been carried out on reddit.com. Of a total of 229 NPSs being discussed at the time of the pandemic, some 18 NPSs were identified for the first time by the NPSfinder®. These included six cathinones, six opioids, two synthetic cannabinoid receptor agonists (SCRAs), two phenylcyclohexylpiperidine (PCP)-like molecules, and two psychedelics. Of these NPSs, 10 were found to be previously unreported to either the UNODC or the EMCDDA. Of these 18 NPSs, opioids and cathinones were the most discussed on social media/reddit, with the highest number of threads associated. Current findings may support the use of both automated web crawlers and social listening approaches to identify emerging NPSs; the pandemic-related imposed restrictions may somehow influence the demand for specific NPS classes.en
dc.format.extent12
dc.language.isoeng
dc.relation.ispartofFrontiers in Psychiatry
dc.subjectCOVID-19
dc.subjectNPS
dc.subjectNPSfinder®
dc.subjectdrug misuse
dc.subjectnew psychoactive substances
dc.subjectweb crawler
dc.subjectPsychiatry and Mental health
dc.titleIdentifying new/emerging psychoactive substances at the time of COVID-19; a web-based approachen
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85101562696&partnerID=8YFLogxK
rioxxterms.versionVoR
rioxxterms.versionofrecordhttps://doi.org/10.3389/fpsyt.2020.632405
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record